ARVEE logo

Arvee Laboratories (India) Ltd. Stock Price

NSEI:ARVEE Community·₹1.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ARVEE Share Price Performance

₹162.75
-6.26 (-3.70%)
₹162.75
-6.26 (-3.70%)
Price ₹162.75

ARVEE Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
0 Rewards

Arvee Laboratories (India) Ltd. Key Details

₹353.7m

Revenue

₹179.6m

Cost of Revenue

₹174.1m

Gross Profit

₹160.3m

Other Expenses

₹13.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
1.25
49.22%
3.89%
3.3%
View Full Analysis

About ARVEE

Founded
2012
Employees
70
CEO
Shalin Patel
WebsiteView website
arveelabs.com

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.

Recent ARVEE News & Updates

Recent updates

No updates